检索

期
标题
作者
卷 80, 编号 12 (2008)
Comparison of effects of carbohydrate metabolism compensation and atorvastatin treatment on lipid metabolism and C-reactive protein in type 2 diabetes mellitus
Glinkina I., Zilov A., Mel'nichenko G., Roytman A., Il'in A., Glinkina I., Zilov A., Melnichenko G., Roitman A., Ilyin A.
卷 93, 编号 10 (2021)
Prognostic factors for the carbohydrate metabolism normalization in patients with type 2 diabetes mellitus and obesity using liraglutide 3.0 mg per day
Sklyanik I., Shestakova M.
PDF
(Rus)
卷 92, 编号 10 (2020)
Association of polymorphisms of genes TCF7L2, FABP2, KCNQ1, ADIPOQ with the prognosis of the development of type 2 diabetes mellitus
Mel’nikova E., Rymar O., Ivanova A., Mustafina S., Shapkina M., Bobak M., Maljutina S., Voevoda M., Maksimov V.
PDF
(Rus)
卷 90, 编号 10 (2018)
The effects of menopausal hormone therapy on proinflammatory cytokines and immunoglobulins in perimenopausal patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease (COPD)
Panevina A., Smetneva N., Vasilenko A., Shestakova M.
PDF
(Rus)
卷 89, 编号 10 (2017)
Risk of type 2 diabetes mellitus in the Kyrgyz population in the presence of ADIPOQ (G276T), KCNJ11 (Glu23Lys), TCF7L2 (IVS3C>T) gene polymorphisms
Isakova Z., Talaibekova E., Asambaeva D., Kerimkulova A., Lunegova O., Aldasheva N., Aldashev A.
PDF
(Rus)
卷 87, 编号 8 (2015)
Type 2 diabetes mellitus: Clinical aspects of genetics, nutrigenetics, and pharmacogenetics
Ametov A., Kamynina L., Akhmedova Z.
卷 86, 编号 8 (2014)
Effect of dipeptidyl peptidase-4 inhibitors on fat metabolism in patients with type 2 diabetes mellitus
Ametov A., Gusenbekova D.
卷 85, 编号 9 (2013)
Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus
Statsenko M., Derevianchenko M., Ostrovskiĭ O., Titarenko M., Shvets M., Bondarev A.
卷 84, 编号 8 (2012)
Diabetes mellitus is an independent risk factor for cardiovascular disease
Ametov A., Kulidzhanian N.
卷 83, 编号 10 (2011)
Heterogenicity of type 2 diabetes mellitus: clinical characteristics of 4 subtypes
Asfandiyarova N., Asfandiyarova N.
卷 82, 编号 3 (2010)
Impact of insulin therapy on insulin resistance and a risk for coronary heart disease and cardiovascular death in patients with type 2 diabetes
Ametov A., Kochergina I., Ulanova K., Ametov A., Kochergina I., Ulanova K.
卷 93, 编号 10 (2021)
Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy
Demidova T., Lobanova K., Perekhodov S., Antsiferov M., Oynotkinova O.
PDF
(Rus)
卷 92, 编号 10 (2020)
Angiogenesis system, as a part of endothelial dysfunction in patients with diabetes mellitus type 2: relationship with obesity
Severina A., Shestakova M.
PDF
(Rus)
卷 90, 编号 10 (2018)
Nephrolithiasis against type 2 diabetes mellitus: on the effect of hypoglycemic therapy on lithogenesis
Yarovoy S., Kareva E., Djalilov O.
PDF
(Rus)
卷 89, 编号 10 (2017)
Glycemic variability and oxidative stress in patients with type 2 diabetes mellitus during combined glucose-lowering therapy
Butaeva S., Ametov A., Bugrov A., Dolgov V.
PDF
(Rus)
卷 87, 编号 10 (2015)
Leptin, resistin, and hormonal and metabolic parameters in women with type 2 diabetes and in those with its concurrence with asthma
Verbovoy A., Kosareva O., Akhmerova R.
卷 86, 编号 10 (2014)
Comparative analysis of the changing pattern of thyroid disease in patients with type 2 diabetes mellitus in the Perm Region after 10 years
Tereshchenko I., Suslina A.
卷 85, 编号 8 (2013)
A combination of dipeptidyl peptidase-4 inhibitor and metformin in the treatment of patients with type 2 diabetes mellitus: effective control of glycemia, weight, and quantitative body composition
Shestakova M., Sukhareva O., Chernova T., Shmushkovich I., Aleksandrov A., Il'in A., Dedov I.
卷 84, 编号 8 (2012)
Evaluation of the efficiency and safety of therapy with a combination of sulfonylurea derivatives and insulin sensitizers for type 2 diabetes mellitus
Goncharenko O., Ametov A., Isakova M.
卷 83, 编号 5 (2011)
Efficacy of pharmacological inhibition of intestinal saccharases in patients with diabetes mellitus type 2 and/or visceral obesity
Ametov A., Kamynina L., Ametov A., Kamynina L.
卷 81, 编号 10 (2009)
Inflammation as a factor of the pathogenesis of insulin resistance and type 2 diabetes
Shvarts V., Schwarz V.
卷 93, 编号 10 (2021)
Leptin and leptin receptor evaluation in atherosclerotic plaques in patients with type 2 diabetes mellitus
Dimitrova D., Mikhailov I., Tokarev K., Michurova M., Gorbacheva A., Danilova N., Malkov P., Kalashnikov V.
PDF
(Rus)
卷 90, 编号 10 (2018)
The prevalence of components of metabolic syndrome in the patients with diabetes melitus type 2 and mody diabetes in young people of Novosibirsk
Mustafina S., Ovsyannikova A., Voevoda M., Denisova D., Sherbakova L., Rymar O.
PDF
(Rus)
卷 89, 编号 10 (2017)
Microcirculatory parameters in compensated and decompensated type 2 diabetes mellitus
Suchkova O., Gurfinkel Y., Sasonko M.
PDF
(Rus)
卷 87, 编号 10 (2015)
The state of the great arteries in type 2 diabetes mellitus patients with obstructive sleep apnea syndrome
Oleynikov V., Sergatskaya N., Gusakovskaya L., Khromova A.
卷 86, 编号 10 (2014)
Secretion of incretin hormones in people having risk factors for type 2 diabetes mellitus
Shestakova E., Il'in A., Shestakova M., Dedov I.
卷 85, 编号 5 (2013)
Osteoarthrosis in patients with type 2 diabetes mellitus
Asfandiiarova N., Nizov A., Nekhaeva T., Sakaeva N., Filatova T., Zhuravleva N., Trunina T.
卷 84, 编号 10 (2012)
The incidence of postoperative myocardial infarction and the left ventricular function in patients with type 2 diabetes mellitus after recanalization of chronic coronary occlusions
Petrenko I., Petrenko O., Popova M., Mamedova S., Urvantseva I.
卷 82, 编号 8 (2010)
Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus
Ametov A., Pyanykh O., Chernikova N.
卷 81, 编号 10 (2009)
Current approaches to controlling type 2 diabetes
Ametov A., Karpova E., Ivanova E., Ametov A., Karpova E., Ivanova E.
卷 92, 编号 8 (2020)
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics
Anisonyan A., Sandler Y., Khaimenova T., Keyan V., Saliev K., Sbikina E., Vinnitskaya E.
PDF
(Rus)
卷 90, 编号 10 (2018)
Oxidative and carbonyl stress as a factors of the modification of proteins and DNA destruction in diabetes
Lankin V., Tikhaze A., Konovalova G., Odinokova O., Doroshchuk N., Chazova I.
PDF
(Rus)
卷 87, 编号 10 (2015)
Cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus and coronary artery disease: Diagnosis and severity assessment
Beshlieva D., Kalashnikov V., Smirnova O.
卷 86, 编号 1 (2014)
The contribution of current investigations to understanding the nature of type 2 diabetes mellitus, and treatment perspectives
Ametov A.
卷 85, 编号 1 (2013)
Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
Ametov A., Kamynina L.
卷 84, 编号 10 (2012)
The degree of alexithymia in type 2 diabetes mellitus patients and its association with medical and demographic parameters
Sapozhnikova I., Tarlovskaia E., Madianov I., Vedenskaia T.
卷 82, 编号 10 (2010)
Innovations in the treatment of type 2 diabetes mellitus: use of incretins
Dedov I., Shestakova M., Sukhareva O., Dedov I., Shestakova M., Sukhareva O.
卷 81, 编号 9 (2009)
Influence of chronic cardiac failure severity on the course of comorbid type 2 diabetes mellitus
Narusov O., Lapina Y., Mareev V., Bolotina M., Shestakova M., Masenko V., Baklanova N., Belenkov Y., Narusov O., Lapina Y., Mareev V., Bolotina M., Shestakova M., Masenko V., Baklanova N., Belenkov Y.
卷 93, 编号 1 (2021)
Cardio-ankle vascular index (CAVI) in diagnostics, risk and severity evaluation of magistral vessels lesion in patients with cardio-vascular diseases and type 2 diabetes
Verner V., Mel’nik M., Knjazeva S.
PDF
(Rus)
卷 92, 编号 5 (2020)
Advantages of therapy with sodium glucose cotransporter type 2 inhibitors in patients with type 2 diabetes mellitus in combination with hyperuricemia and gout
Panevin T., Eliseev M., Shestakova M., Nasonov E.
PDF
(Rus)
卷 90, 编号 10 (2018)
Immunogenic lipid markers of atherosclerosis in type 2 diabetic patients on program haemodialysis
Archakova T., Nedosugova L., Nikitina N., Melnichenko A., Sobenin I.
PDF
(Rus)
卷 89, 编号 4 (2017)
Chronic constipation in the practice of a therapist: Features of therapy for comorbidity
Svistunov A., Osadchuk M., Butorova L., Tokmulina G.
PDF
(Rus)
卷 87, 编号 6 (2015)
Increased serum concentrations of inflammatory cytokines in type 2 diabetic patients with chronic kidney disease
Konenkov V., Klimontov V., Myakina N., Tyan N., Fazullina O., Romanov V.
卷 85, 编号 2 (2013)
Clinical characteristics of dyspepsia in patients with diabetes mellitus type 2
Osipenko M., Zhuk E., Medvedeva O.
卷 84, 编号 9 (2012)
Pharmacogenetic features of the effect of metformin in patients with coronary heart disease in the presence of metabolic syndrome and type 2 diabetes mellitus in terms of PPAR-γ2 gene polymorphism
Lavrenko A., Shlykova O., Kutsenko L., Mamontova T., Kaĭdashev I.
卷 82, 编号 8 (2010)
Correlation of HbA1c and postprandial glycemia during a standard breakfast test in patients with type 2 diabetes receiving glibenclamide
Dreval A., Cheporeva O., Redkin Y., Misnikova I.
卷 81, 编号 5 (2009)
Long-term results of coronary endovascular revascularisation with eluting sirolimus-stents in patients with coronary heart disease comorbid with type-2 diabetes mellitus: evidence from 18-month prospective study
Teplyakov A., Torim Y., Kuznetsova A., Rybal'chenko E., Krylov A., Karpov R., Teplyakov A., Torim Y., Kuznetsova A., Rybalchenko E., Krylov A., Karpov R.
51 - 97 的 97 信息 << < 1 2 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##